Cancer Research Technology Limited (CRT, the specialist oncology development and commercialisation company), and The Norwegian Radium Hospital Research Foundation (the NRHRF, office of technology transfer and industrial relations for The Norwegian Radium Hospital) today announce a strategic alliance to co-develop novel cancer therapeutics and diagnostics.